Showing results (11-20 of 172) with videos related to

Sort By:
Pageof 18
Plos One|September 16, 2016
New Insights into the Pro-Inflammatory Activities of Ang1 on Neutrophils: Induction of MIP-1β Synthesis and ReleaseElizabeth Dumas, Paul-Eduard Neagoe, Patrick P McDonald, et al.
Transplantation|August 18, 2020
Myocardial Vascular Function Assessed by Dynamic Oxygenation-sensitive Cardiac Magnetic Resonance Imaging Long-term Following Cardiac TransplantationNadia Iannino, Kady Fischer, Matthias Friedrich, et al.
The Canadian Journal of Cardiology|December 7, 2007
Heart rate recovery--a potential marker of clinical outcomes in heart failure patients receiving beta-blocker therapyRichard J Sheppard, Normand Racine, Andre Roof, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 2, 2010
Enantioselective quantification of carvedilol in human plasma by HPLC in heavily medicated heart failure patientsMarcin Zakrzewski-Jakubiak, Simon de Denus, Marie-Hélène Leblanc, et al.
Clinical Transplantation|April 30, 2009
Impact of ezetimibe on cholesterol subfractions in dyslipidemic cardiac transplant recipients receiving statin therapyVy-Van Le, Normand Racine, Guy B Pelletier, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 22, 2009
Relationship between adherence level to statins, clinical issues and health-care costs in real-life clinical settingAlice Dragomir, Robert Côté, Michel White, et al.
European Journal of Clinical Pharmacology|June 17, 2009
Impact of better adherence to statin agents in the primary prevention of coronary artery diseaseSylvie Perreault, Alice Dragomir, Lucie Blais, et al.
Circulation|March 12, 2003
Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD)Emmanuelle Vermes, Anique Ducharme, Martial G Bourassa, et al.
British Journal of Clinical Pharmacology|January 19, 2010
Adherence level of antihypertensive agents in coronary artery diseaseSylvie Perreault, Alice Dragomir, Louise Roy, et al.
Therapeutic Advances in Cardiovascular Disease|March 21, 2009
Effects of enalapril, candesartan or both on neurohumoral activation and LV volumes and function in patients with heart failure not treated with a beta-blockerMichel White, Jean-Lucien Rouleau, Rizwan Afzal, et al.
Pageof 18